Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BM.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BM.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.357EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.357EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.357ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.357ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.357EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.357EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.357ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.357ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.579EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.579EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.579ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.579ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.579EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.579EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.579ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.579ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
N.10EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
N.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
N.10ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
N.10ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
N.10EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
N.10EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
N.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
N.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
P.1.11 (Gamma)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
P.1.11 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.11 (Gamma)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
P.1.11 (Gamma)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
P.1.11 (Gamma)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
P.1.11 (Gamma)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
P.1.11 (Gamma)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
P.1.11 (Gamma)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.435EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.435EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.435ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.435ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.435EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.435EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.435ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.435ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.445EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.445EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.445ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.445ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.445EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.445EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.445ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.445ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used